Van Strydonck, Gerald E.

Gerald E. Van Strydonck serves as a Director at Vaccinex, Inc., a biotechnology company focused on developing therapies for cancer and neurodegenerative diseases. His recent trading activity includes multiple sales of Vaccinex, Inc. (VCNX) shares, with a notable transaction valued at $58.1K on May 14, 2024. This profile details his insider disclosures from December 12, 2023, to May 14, 2024, highlighting a total of four disclosures, all related to the healthcare sector.